MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Novel modifiers of heterozygous pathogenic Parkin variant penetrance in Parkinson’s disease

    A. Hach, Z. Landoulsi, B. Meier, P. Seibler, C. Klein, P. May, A. Rakovic (Luebeck, Germany)

    Objective: To identify novel genes and pathways acting as modifiers of pathogenic Parkin variant (PV) penetrance in affected compared to unaffected carriers of heterozygous Parkin PVs…
  • 2023 International Congress

    A 16-week open-label study of the effects of treatment with pimavanserin on activities of daily living in subjects with Parkinson’s disease psychosis (PDP)

    V. Evidente, D. Dekarske, B. Coate, V. Abler (Scottsdale, USA)

    Objective: To examine the effects of pimavanserin on activities of daily living during treatment for Parkinson’s Disease psychosis. Background: Accurate assessment of disability associated with…
  • 2023 International Congress

    Olfactory dysfunction as a predictor of the future development of parkinsonism in COVID patients

    M. de Rosa, D. Calisi, L. Bonanni, M. Onofrj (Chieti, Italy)

    Objective: Olfactory dysfunction due to SARS-CoV-2 infection as a prodromal stage of PD. Background: Olfactory dysfunction due to SARS-CoV-2 disease can depend on the neuroinvasive properties…
  • 2023 International Congress

    Bilateral subthalamic nucleus deep brain stimulation in Parkinson’s disease: preoperative predictors of speech worsening

    F. Cavallieri, F. Bove, A. Zampogna, A. Castrioto, S. Meoni, A. Gessani, E. Schmitt, A. Bichon, E. Lhommée, P. Pélissier, A. Kistner, E. Chevrier, F. Valzania, E. Seigneuret, S. Pinto, S. Chabardès, V. Fraix, E. Moro (Reggio Emilia, Italy)

    Objective: To find preoperative predictive factors of short-term postoperative speech worsening in a large cohort of consecutive PD patients treated with bilateral STN-DBS. Background: Subthalamic…
  • 2023 International Congress

    6-[18F]fluoro-L-3,4-dihydroxyphenylalanine (F-DOPA) PET striatal binding patterns in patients with Parkinson’s Disease and Parkinson Plus Syndromes.

    A. Buckland, T. Lee, R. Stell, S. Ghosh, J. Rodrigues, W. Yau, S. Vijayan, R. Francis, K. Sek, L. Morandeau, A. Jacques, T. Hagan, J. Watts, E. Campbell, N. Loh (Nedlands, Australia)

    Objective: In this study we investigate striatal binding patterns in patients with Idiopathic Parkinson’s disease (IPD), compared to those with Parkinson Plus syndromes (PPS) versus…
  • 2023 International Congress

    Detection and classification of GBA variants PD-related: is there sex unbalance?

    C. Reale, C. Panteghini, I. Colangelo, M. Suerz, R. Cilia, R. Eleopra, B. Garavaglia, F. Invernizzi (Milan, Italy)

    Objective: This study aims to classify GBA variants detected in the Genetic Movement Disorders Laboratory (GMDL) of the Neurological Institute “Carlo Besta” in Milan over…
  • 2023 International Congress

    Concealment of Parkinson’s Disease: Prevalence and Impact on Health and Quality of Life

    G. Yogev-Seligmann, B. Naamneh Abuelhija, M. Giveon, M. Meir Kestenbaum, M. Kafri (Haifa, Israel)

    Objective: (1) To explore the proportion and personal characteristics of patients who do not disclose their diagnosis of Parkinson's disease (PD) to their family, and…
  • 2023 International Congress

    Effectiveness of speech therapy in patients with Parkinson’s disease – a randomized controlled trial

    J. Maas, N. de Vries, B. Bloem, H. Kalf (Nijmegen, Netherlands)

    Objective: We aimed to assess the effectiveness of speech therapy on improving quality of life and speech quality in patients with Parkinson’s disease. Background: Although…
  • 2023 International Congress

    Structural MRI and tremor analysis in the differential diagnosis of rest tremor

    F. Aracri, M. Bianco, C. Calomino, M. de Maria, B. Vescio, J. Buonocore, A. Sarica, A. Quattrone (Catanzaro, Italy)

    Objective: This study aimed to differentiate between essential tremor with rest tremor (rET) and tremor-dominant Parkinson’s disease (td-PD) patients through a machine learning (ML) approach…
  • 2023 International Congress

    A Novel Real Time Algorithm to Predict Freezing of Gait in Parkinson’s Patients Using Wearable Mobility Sensors Data

    N. Galor, T. Krasovsky, S. Hassin, B. Heimler, M. Plotnik (Ramat Gan, Israel)

    Objective: To develop an algorithm for real-time Freezing of gait (FOG) prediction based on the online monitoring of the stepping coherence. Background: FOG is a…
  • « Previous Page
  • 1
  • …
  • 95
  • 96
  • 97
  • 98
  • 99
  • …
  • 338
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley